Search Results - "Ranjan, Ajenthen G."

Performance of a dual-hormone closed-loop system versus insulin-only closed-loop system in adolescents with type 1 diabetes. A single-blind, randomized, controlled, crossover trial by Lindkvist, Emilie Bundgaard, Laugesen, Christian, Reenberg, Asbjørn Thode, Ritschel, Tobias Kasper Skov, Svensson, Jannet, Jørgensen, John Bagterp, Nørgaard, Kirsten, Ranjan, Ajenthen G

“…To assess the efficacy and safety of a dual-hormone (DH [insulin and glucagon]) closed-loop system compared to a single-hormone (SH [insulin only]) closed-loop…”
Get full text

Sensor-Based Glucose Metrics during Different Diet Compositions in Type 1 Diabetes-A Randomized One-Week Crossover Trial by Kristensen, Kasper B, Ranjan, Ajenthen G, McCarthy, Olivia M, Bracken, Richard M, Nørgaard, Kirsten, Schmidt, Signe

“…By reducing carbohydrate intake, people with type 1 diabetes may reduce fluctuations in blood glucose, but the evidence in this area is sparse. The aim of this…”
Get full text

Glycemia Around Exercise in Adults with Type 1 Diabetes Using Automated and Nonautomated Insulin Delivery Pumps: A Switch Pilot Trial by McCarthy, Olivia M, Christensen, Merete Bechmann, Kristensen, Kasper Birch, Schmidt, Signe, Ranjan, Ajenthen G, Bain, Stephen C, Bracken, Richard M, Nørgaard, Kirsten

“…In an in-patient switch study, 10 adults with type 1 diabetes (T1D) performed 45 min of moderate-intensity exercise on 2 occasions: (1) when using their usual…”
Get more information

A collaborative comparison of international pediatric diabetes registries by Lanzinger, Stefanie, Zimmermann, Anthony, Ranjan, Ajenthen G., Gani, Osman, Pons Perez, Saira, Akesson, Karin, Majidi, Shideh, Witsch, Michael, Hofer, Sabine, Johnson, Stephanie, Pilgaard, Kasper A., Kummernes, Siv Janne, Robinson, Holly, Eeg‐Olofsson, Katarina, Ebekozien, Osagie, Holl, Reinhard W., Svensson, Jannet, Skrivarhaug, Torild, Warner, Justin, Craig, Maria E., Maahs, David

“…Background An estimated 1.1 million children and adolescents aged under 20 years have type 1 diabetes worldwide. Principal investigators from seven…”
Get full text

Effect of adjunctive glucose-lowering drugs on body weight in people with type 1 diabetes: a systematic review and network meta-analysis protocol by Laugesen, Christian, Ranjan, Ajenthen G., Schmidt, Signe, Rasmussen, Lauge Neimann, Nørgaard, Ole, Christensen, Robin, Nørgaard, Kirsten

“…IntroductionObesity increases the risk of comorbidities and diabetes-related complications and, consequently, efforts to prevent and reduce excess weight in…”
Get full text

Time spent in hypoglycemia is comparable when the same amount of exercise is performed 5 or 2 days weekly: a randomized crossover study in people with type 1 diabetes by Steineck, Isabelle Isa Kristin, Ranjan, Ajenthen G, Schmidt, Signe, Norgaard, Kirsten

“…IntroductionPeople with type 1 diabetes are recommended to exercise regularly. However, limited evidence exists on how frequency and duration of exercise…”
Get full text

Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post‐hoc analysis of a randomized crossover trial by Al‐Sari, Naba, Schmidt, Signe, Suvitaival, Tommi, Kim, Min, Trošt, Kajetan, Ranjan, Ajenthen G., Christensen, Merete B., Overgaard, Anne J., Pociot, Flemming, Nørgaard, Kirsten, Legido‐Quigley, Cristina

“…Aims Lipid metabolism might be compromised in type 1 diabetes, and the understanding of lipid physiology is critically important. This study aimed to compare…”
Get full text

Low-Dose Dasiglucagon Versus Oral Glucose for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes: A Phase 2, Randomized, Three-Arm Crossover Study by Laugesen, Christian, Ranjan, Ajenthen G, Schmidt, Signe, Nørgaard, Kirsten

“…To compare the efficacy of low-dose subcutaneous dasiglucagon with oral glucose for prevention of insulin-induced hypoglycemia in people with type 1 diabetes…”
Get full text

Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 Diabetes by Ranjan, Ajenthen G, Rosenlund, Signe V, Hansen, Tine W, Rossing, Peter, Andersen, Steen, Nørgaard, Kirsten

“…To investigate the association between treatment-induced change in continuous glucose monitoring (CGM) time in range (TIR) and albuminuria in persons with type…”
Get full text

Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial by Laugesen, Christian, Ranjan, Ajenthen G., Schmidt, Signe, Nørgaard, Kirsten

“…Aims/hypothesis Consumption of excess carbohydrates to manage hypoglycaemia can lead to rebound hyperglycaemia and promote weight gain. The objective of this…”
Get full text

257-OR: Pen-Administered Low-Dose Dasiglucagon vs. Usual Care for Prevention and Treatment of Nonsevere Hypoglycemia in People with Type 1 Diabetes during Free-Living Conditions: A Phase 2, Randomized, Two-Period, Crossover Outpatient Study by LAUGESEN, CHRISTIAN, RANJAN, AJENTHEN G., SCHMIDT, SIGNE, NØRGAARD, KIRSTEN

“…Objective: To evaluate the efficacy, safety and feasibility of pen-administered low-dose dasiglucagon for prevention and treatment of non-severe hypoglycemia…”
Get full text

Glucagon for hypoglycaemia treatment in type 1 diabetes by Ranjan, Ajenthen G., Schmidt, Signe, Nørgaard, Kirsten

“…To achieve strict glycaemic control and avoid chronic diabetes complications, individuals with type 1 diabetes (T1D) are recommended to follow an intensive…”
Get full text

Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study by Nørgaard, Kirsten, Ranjan, Ajenthen G., Laugesen, Christian, Tidemand, Katrine G., Green, Allan, Selmer, Christian, Svensson, Jannet, Andersen, Henrik U., Vistisen, Dorte, Carstensen, Bendix

“…OBJECTIVE This study aimed to investigate the association between continuous glucose monitoring (CGM)-derived glycemic metrics and different insulin treatment…”
Get full text

Effects of a Low-Carbohydrate-High-Protein Pre-Exercise Meal in Type 1 Diabetes—a Randomized Crossover Trial by Kristensen, Kasper B, Ranjan, Ajenthen G, McCarthy, Olivia M, Holst, Jens J, Bracken, Richard M, Nørgaard, Kirsten, Schmidt, Signe

“…Abstract Context Current guidelines for exercise-related glucose management focus on reducing bolus and/or basal insulin doses and considering carbohydrate…”
Get full text

129-LB: A Comparison of CGM Metrics in People with Type 1 Diabetes Treated with Different Insulin Modalities by NØRGAARD, KIRSTEN, RANJAN, AJENTHEN G., LAUGESEN, CHRISTIAN, TIDEMAND, KATRINE G., ANDERSEN, HENRIK U., SVENSSON, JANNET, SELMER, CHRISTIAN, GREEN, ALLAN, VISTISEN, DORTE, CARSTENSEN, BENDIX

“…Background: There is a lack of real-world data comparing CGM data across different insulin treatment modalities. This study examined the association between…”
Get full text

Automated Insulin Delivery in Adults With Type 1 Diabetes and Suboptimal HbA1c During Prior Use of Insulin Pump and Continuous Glucose Monitoring: A Randomized Controlled Trial by Christensen, Merete B, Ranjan, Ajenthen G, Rytter, Karen, McCarthy, Olivia M, Schmidt, Signe, Nørgaard, Kirsten

“…Automated insulin delivery (AID) systems offer promise in improving glycemic outcomes for individuals with type 1 diabetes. However, data on those who struggle…”
Get full text

215-OR: Performance of a Dual Hormone Closed-Loop System vs. an Insulin-Only Closed-Loop System during Challenging Inpatient Conditions: A Single-Blinded Randomized Controlled Crossover Trial by RANJAN, AJENTHEN G., BOIROUX, DIMITRI, LAUGESEN, CHRISTIAN, SCHMIDT, SIGNE, REENBERG, ASBJØRN T., JØRGENSEN, JOHN B., NØRGAARD, KIRSTEN

“…Objective: To assess the efficacy and safety of an insulin-glucagon dual-hormone (DH) compared with an insulin-only single-hormone (SH) closed-loop system…”
Get full text

The effect of preceding glucose decline rate on low‐dose glucagon efficacy in individuals with type 1 diabetes: A randomized crossover trial by Laugesen, Christian, Schmidt, Signe, Holst, Jens Juul, Nørgaard, Kirsten, Ranjan, Ajenthen G.

“…Identifying determinants of low‐dose glucagon efficacy is important to optimise its utilization for prevention and treatment of hypoglycaemia in individuals…”
Get full text

Automated Insulin Delivery in Adults With Type 1 Diabetes and Suboptimal HbA 1c During Prior Use of Insulin Pump and Continuous Glucose Monitoring: A Randomized Controlled Trial by Christensen, Merete B, Ranjan, Ajenthen G, Rytter, Karen, McCarthy, Olivia M, Schmidt, Signe, Nørgaard, Kirsten

“…Automated insulin delivery (AID) systems offer promise in improving glycemic outcomes for individuals with type 1 diabetes. However, data on those who struggle…”
Get full text

Cardiovascular Autonomic Neuropathy Is Associated With Increased Glucose Variability in People With Type 1 Diabetes by Naaman, Sara H., Mizrak, Hatice I., Lind, Nanna, Laursen, Jens C., Kufaishi, Huda, Christensen, Marie M.B., Ranjan, Ajenthen G., Nørgaard, Kirsten, Hansen, Christian S.

“…OBJECTIVE We investigated the association between the cardiovascular autonomic neuropathy (CAN) diagnosis and glucose variability (GV) in type 1 diabetes…”
Get full text